Remegen Co., Ltd.

This study tests a new drug combination (RC48-ADC plus toripalimab and either chemotherapy or trastuzumab) as a first treatment for advanced stomach cancer that has spread. About 201 adults with or without a specific protein (HER2) will participate. The goal is to see if the comb…

This study tests a drug called telitacicept in 318 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. The goal is to see if the drug can reduce protein in the urine and slow the loss of kidney function compared to a placebo. All participants are alread…

This early-stage trial tests an experimental drug called RC148 in 121 people with advanced non-small cell lung cancer that cannot be removed by surgery. The drug is given alone or with other treatments to see if it can shrink tumors and control the disease. Participants must be i…